Adenosine monophosphate bronchial provocation and the actions of asthma therapy
- 5 March 2003
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 33 (3), 287-294
- https://doi.org/10.1046/j.1365-2745.2003.01620.x
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary diseaseThorax, 2002
- Role of cysteinyl leukotrienes in adenosine 5`-monophosphate induced bronchoconstriction in asthmaThorax, 2002
- Sustained bronchoprotection with montelukast but not formoterol as add on therapy in asthmatics with the homozygous glycine 16 b2 adrenoceptor genotypeJournal of Allergy and Clinical Immunology, 2002
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Theophylline: Recent Advances in the Understanding of Its Mode of Action and Uses in Clinical PracticeMayo Clinic Proceedings, 1998
- Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.Thorax, 1998
- Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutalineThorax, 1997
- Adenosine-induced bronchoconstriction and its inhibition by nedocromil sodiumJournal of Allergy and Clinical Immunology, 1993
- Nedocromil sodium is more potent than sodium cromoglycate against AMP‐induced bronchoconstriction in atopic asthmatic subjectsClinical and Experimental Allergy, 1989
- The Role of Histamine in Allergen and Adenosine-Induced BronchoconstrictionInternational Archives of Allergy and Immunology, 1987